Third Harmonic Bio, Inc. (THRD)
USD 5.17
(0.19%)
USD 5.17
(0.19%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -265.11 Million USD | 6.83% |
| 2022 | -284.53 Million USD | -121.81% |
| 2021 | -128.28 Million USD | -1449.84% |
| 2020 | -8.27 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -259.05 Million USD | 2.29% |
| 2024 Q2 | -251.73 Million USD | 2.82% |
| 2023 Q2 | -273.84 Million USD | 1.41% |
| 2023 Q3 | -269.77 Million USD | 1.49% |
| 2023 Q4 | -265.11 Million USD | 1.72% |
| 2023 Q1 | -277.75 Million USD | 2.38% |
| 2023 FY | -265.11 Million USD | 6.83% |
| 2022 Q1 | 128.28 Million USD | 200.0% |
| 2022 FY | -284.53 Million USD | -121.81% |
| 2022 Q4 | -284.53 Million USD | 5.0% |
| 2022 Q3 | -299.51 Million USD | -165.69% |
| 2022 Q2 | -112.73 Million USD | -187.88% |
| 2021 Q1 | 8.27 Million USD | 0.0% |
| 2021 Q4 | -128.28 Million USD | 0.0% |
| 2021 FY | -128.28 Million USD | -1449.84% |
| 2020 FY | -8.27 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Absci Corporation | -72.59 Million USD | -265.185% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 261.295% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 114.178% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -351822.107% |
| Apollomics, Inc. | -27.39 Million USD | -867.757% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -40330.818% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -199.703% |
| Bicycle Therapeutics plc | -481.46 Million USD | 44.936% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -105.336% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 833.117% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 6479.139% |
| Chimerix, Inc. | -25.51 Million USD | -938.982% |
| CRISPR Therapeutics AG | -150.84 Million USD | -75.755% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 249.222% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 3.871% |
| Fortress Biotech, Inc. | 7.66 Million USD | 3558.8% |
| Fortress Biotech, Inc. | 7.66 Million USD | 3558.8% |
| Gritstone bio, Inc. | 39.49 Million USD | 771.352% |
| Allakos Inc. | -24.97 Million USD | -961.53% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -1132.472% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -2840.517% |
| Cytokinetics, Incorporated | 642.37 Million USD | 141.272% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -269.537% |
| Innoviva, Inc. | 255.56 Million USD | 203.738% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -2770.105% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 36118.102% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -553.448% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -4625.568% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -234.225% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -595.079% |
| ImmuCell Corporation | 10.99 Million USD | 2512.224% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | -71.991% |
| Incyte Corporation | -3.17 Billion USD | 91.65% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 1767.572% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -22213.71% |
| Mustang Bio, Inc. | -3.73 Million USD | -6996.279% |
| MiMedx Group, Inc. | -33.9 Million USD | -682.033% |
| MEI Pharma, Inc. | -3.7 Million USD | -7055.655% |
| MacroGenics, Inc. | -66.98 Million USD | -295.786% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -3548.694% |
| Mereo BioPharma Group plc | -51.46 Million USD | -415.1% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -1654.411% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -2495.624% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 836.334% |
| Minerva Neurosciences, Inc. | 41 Million USD | 746.56% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -1092.502% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -10345.902% |
| NextCure, Inc. | -6.47 Million USD | -3993.207% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -818.25% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -424.974% |
| Onconetix, Inc. | 5.33 Million USD | 5072.712% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -4056.09% |
| Opthea Limited | 28.15 Million USD | 1041.552% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 1498.281% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 3945.286% |
| PDS Biotechnology Corporation | -32.7 Million USD | -710.535% |
| Precigen, Inc. | -481 Thousand USD | -55017.879% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -1424.011% |
| Prime Medicine, Inc. | -27.94 Million USD | -848.846% |
| PureTech Health plc | -167.19 Million USD | -58.566% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -759.04% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -878.292% |
| Replimune Group, Inc. | 1.41 Million USD | 18875.992% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -2110.837% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 1053.898% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -11342.12% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 56.41% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -1331.528% |
| Sesen Bio, Inc. | -112.55 Million USD | -135.549% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -3634.042% |
| Solid Biosciences Inc. | -47.75 Million USD | -455.219% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 9.75% |
| SciSparc Ltd. | -2.06 Million USD | -12738.596% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 333.622% |
| TG Therapeutics, Inc. | 17.86 Million USD | 1584.251% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -1651.682% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -4170.57% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 176.489% |
| UroGen Pharma Ltd. | 4.39 Million USD | 6137.736% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -1002.954% |
| XOMA Corporation | -29 Million USD | -814.197% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 1594.88% |
| AbCellera Biologics Inc. | -55.94 Million USD | -373.931% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -1813.373% |
| Cassava Sciences, Inc. | -121.13 Million USD | -118.859% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 3904.737% |
| Precision BioSciences, Inc. | -85.41 Million USD | -210.405% |
| Dyadic International, Inc. | -6.37 Million USD | -4056.677% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -3056.906% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -1563.949% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -770.378% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -697.177% |
| IGM Biosciences, Inc. | -72.6 Million USD | -265.145% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -543.722% |
| Acelyrin, Inc. | -216.9 Million USD | -22.228% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -2822.043% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -1479.111% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -3003.26% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 16.311% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -242.303% |
| Senti Biosciences, Inc. | 1.74 Million USD | 15336.609% |
| Mesoblast Limited | 55.96 Million USD | 573.736% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -948.225% |
| ChromaDex Corporation | -24.04 Million USD | -1002.449% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -30652.857% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 532.795% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -3464.294% |
| Seer, Inc. | -4.24 Million USD | -6152.759% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 263.914% |
| Novavax, Inc. | -298.29 Million USD | 11.122% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -2800.144% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 529.924% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -5279.809% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -221.432% |
| Celcuity Inc. | 6.78 Million USD | 4008.258% |
| ContextLogic Inc. | -232 Million USD | -14.275% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | -9.388% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -139.845% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 105.776% |
| Amarin Corporation plc | -191.04 Million USD | -38.776% |
| AnaptysBio, Inc. | -18.15 Million USD | -1360.619% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -2203.963% |
| Aptorum Group Limited | 1.35 Million USD | 19636.331% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -301.96% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 6294.322% |
| Ardelyx, Inc. | 34.51 Million USD | 868.188% |
| Celularity Inc. | 65.19 Million USD | 506.684% |
| Omeros Corporation | 331.17 Million USD | 180.053% |
| Humacyte, Inc. | -22.48 Million USD | -1079.031% |
| Immunocore Holdings plc | -358.59 Million USD | 26.068% |
| IO Biotech, Inc. | -140.69 Million USD | -88.428% |
| GT Biopharma, Inc. | -1.02 Million USD | -25866.405% |
| Cabaletta Bio, Inc. | -188.22 Million USD | -40.855% |
| Summit Therapeutics Inc. | 34.67 Million USD | 864.599% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -4273.425% |
| Pulmatrix, Inc. | -10.41 Million USD | -2445.042% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -137.982% |
| Evogene Ltd. | -19.63 Million USD | -1250.295% |
| CorMedix Inc. | -43.05 Million USD | -515.799% |
| BioLineRx Ltd. | 7.33 Million USD | 3713.918% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -126.507% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -253.141% |
| PTC Therapeutics, Inc. | -178.97 Million USD | -48.131% |
| scPharmaceuticals Inc. | -6.54 Million USD | -3950.68% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -1698.379% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -95.803% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 36118.102% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -1331.528% |
| Akero Therapeutics, Inc. | -208.16 Million USD | -27.36% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -185.8% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -1089.506% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | -43.612% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -894.475% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 2279.653% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -1488.272% |
| Daré Bioscience, Inc. | -5.15 Million USD | -5040.007% |
| bluebird bio, Inc. | 108.57 Million USD | 344.188% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 169.998% |
| DBV Technologies S.A. | -126.98 Million USD | -108.777% |
| Avidity Biosciences, Inc. | -175.23 Million USD | -51.297% |
| Galecto, Inc. | -21.21 Million USD | -1149.609% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -3797.06% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -189.019% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -291.126% |
| GlycoMimetics, Inc. | -40.98 Million USD | -546.873% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 327.387% |
| ADMA Biologics, Inc. | 90.06 Million USD | 394.359% |
| Clene Inc. | 3.34 Million USD | 8037.635% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 22.959% |
| Aptose Biosciences Inc. | -8.19 Million USD | -3135.163% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -8372.85% |
| Soligenix, Inc. | -4.95 Million USD | -5254.172% |
| Century Therapeutics, Inc. | 847 Thousand USD | 31400.708% |
| Kura Oncology, Inc. | -20.11 Million USD | -1217.81% |
| Surrozen, Inc. | -32.66 Million USD | -711.649% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -547.796% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 14653.314% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -8192.681% |
| Autolus Therapeutics plc | -186.59 Million USD | -42.078% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -437.719% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 873.658% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -1019.724% |
| GRI Bio, Inc. | -1.79 Million USD | -14677.982% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -2851.304% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 5067.529% |
| INmune Bio, Inc. | -25.41 Million USD | -943.316% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 275.631% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -423.336% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -1531.552% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -2753.412% |
| Jaguar Health, Inc. | 29.39 Million USD | 1002.035% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -9089.733% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 797.401% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 1982.8% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 931.479% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 170.146% |
| Verastem, Inc. | -37.27 Million USD | -611.189% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -411.197% |
| Histogen Inc. | -7.48 Million USD | -3441.031% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -1127.006% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -101.684% |
| Surrozen, Inc. | -32.66 Million USD | -711.649% |
| Organovo Holdings, Inc. | -1.5 Million USD | -17492.369% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -6207.072% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -3063.253% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -510.278% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -1718.752% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -36616.755% |
| Kronos Bio, Inc. | -36.05 Million USD | -635.333% |
| Turnstone Biologics Corp. | -14.58 Million USD | -1717.862% |
| Synaptogenix, Inc. | -28.66 Million USD | -824.994% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -28224.466% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 42316.083% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 644.031% |
| Exelixis, Inc. | -73.05 Million USD | -262.925% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -1004.056% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | -9.838% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -215.236% |
| ESSA Pharma Inc. | -33.62 Million USD | -688.532% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -9972.299% |
| Avid Bioservices, Inc. | 169.72 Million USD | 256.201% |
| Insmed Incorporated | 721.62 Million USD | 136.739% |
| MediWound Ltd. | -5.32 Million USD | -4881.53% |
| OmniAb, Inc. | 9.2 Million USD | 2980.767% |
| Alector, Inc. | -35.63 Million USD | -643.937% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 408.38% |
| Zai Lab Limited | -775 Million USD | 65.791% |
| AlloVir, Inc. | -62.69 Million USD | -322.888% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 177.849% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -1912.884% |
| Aura Biosciences, Inc. | -21.52 Million USD | -1131.67% |
| Immunic, Inc. | -45.34 Million USD | -484.731% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | -37.213% |
| Veracyte, Inc. | -203.82 Million USD | -30.072% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 141.535% |
| FibroGen, Inc. | 56.76 Million USD | 567.027% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 3077.17% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -97.732% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -9277.761% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -12705.432% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -7835.259% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | -59.744% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 116.893% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -983.348% |
| XBiotech Inc. | -200.02 Million USD | -32.543% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -215.236% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 16.288% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -15278.016% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 5955.057% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -651.828% |
| Agenus Inc. | 274.13 Million USD | 196.71% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -243.336% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 4758.531% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | -55.571% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -187.004% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 136.008% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -2362.185% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -376.709% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -7578.601% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -2853.603% |
| Lantern Pharma Inc. | -21.7 Million USD | -1121.553% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -6169.023% |
| Ainos, Inc. | 4.07 Million USD | 6601.267% |
| Pluri Inc. | 22.82 Million USD | 1261.317% |
| Prothena Corporation plc | -608.34 Million USD | 56.42% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -123.245% |
| Rallybio Corporation | -24.1 Million USD | -999.979% |
| Kodiak Sciences Inc. | -103.87 Million USD | -155.227% |
| Cue Biopharma, Inc. | -33.81 Million USD | -683.929% |
| MeiraGTx Holdings plc | -40.3 Million USD | -557.826% |
| Annexon, Inc. | -193.75 Million USD | -36.831% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -1415.041% |
| Moderna, Inc. | -2.9 Billion USD | 90.88% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -978.808% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -757.956% |
| Blueprint Medicines Corporation | 702.83 Million USD | 137.721% |
| Immix Biopharma, Inc. | -17.5 Million USD | -1414.107% |
| CalciMedica, Inc. | -5.53 Million USD | -4694.159% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -223.069% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -562.18% |
| Wave Life Sciences Ltd. | -168.23 Million USD | -57.589% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -697.272% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -4335.62% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -342.274% |
| Nutriband Inc. | -251.65 Thousand USD | -105248.55% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -677.036% |
| Vor Biopharma Inc. | 4.3 Million USD | 6265.512% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 95.608% |
| Alkermes plc | -166.73 Million USD | -59.001% |
| ProKidney Corp. | -56.23 Million USD | -371.436% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -444.701% |
| Arcellx, Inc. | -296.95 Million USD | 10.722% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 119.438% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -865.29% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 674.505% |
| Atai Life Sciences N.V. | -28.55 Million USD | -828.346% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 11985.835% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -1061.978% |
| MediciNova, Inc. | -50.78 Million USD | -422.053% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -236.422% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -1178459.68% |
| GeoVax Labs, Inc. | -6.45 Million USD | -4008.692% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | -32.677% |
| Biomea Fusion, Inc. | -166.57 Million USD | -59.163% |
| RenovoRx, Inc. | -1.17 Million USD | -22501.62% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -179.53% |
| Geron Corporation | 14.76 Million USD | 1896.064% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 5906.329% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | -13.087% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -181.408% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -177.041% |
| Royalty Pharma plc | 5.65 Billion USD | 104.685% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -578.517% |
| Imunon, Inc. | -4.21 Million USD | -6191.559% |
| BioAtla, Inc. | -109.01 Million USD | -143.202% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 2315.586% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -1150.375% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -88.386% |
| Structure Therapeutics Inc. | -124.33 Million USD | -113.221% |
| 89bio, Inc. | -289.05 Million USD | 8.281% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -1500.948% |
| aTyr Pharma, Inc. | -7.44 Million USD | -3459.095% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -112.713% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -224.187% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -30756.836% |
| Akari Therapeutics, Plc | -3.84 Million USD | -6795.111% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 16436.104% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 119.199% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 417.129% |
| Liquidia Corporation | -80.17 Million USD | -230.669% |
| Entera Bio Ltd. | -10.62 Million USD | -2394.28% |
| GH Research PLC | -78.07 Million USD | -239.558% |
| Vericel Corporation | 1.27 Million USD | 20860.924% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -1409.434% |
| Xencor, Inc. | 29.64 Million USD | 994.336% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -13359.0% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -1531.552% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -108151.67% |
| Vaxcyte, Inc. | -368.22 Million USD | 28.002% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -92.476% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -109.716% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -22213.71% |
| Portage Biotech Inc. | -4.98 Million USD | -5222.566% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -1178459.68% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -300.951% |
| OncoCyte Corporation | -6.56 Million USD | -3939.57% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 29642.362% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -5719.53% |
| Purple Biotech Ltd. | -14.13 Million USD | -1775.209% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -1327.74% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -4424.181% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -350.718% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -1016.0% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -1053.887% |
| United Therapeutics Corporation | -507.7 Million USD | 47.781% |
| HilleVax, Inc. | -165.48 Million USD | -60.206% |
| Silo Pharma, Inc. | -3.52 Million USD | -7422.526% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 265830.838% |
| Pharming Group N.V. | 109.8 Million USD | 341.446% |
| Tharimmune, Inc. | -10.93 Million USD | -2324.403% |
| Genprex, Inc. | -6.73 Million USD | -3834.871% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -127.995% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 28.115% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 2700.461% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -18823.412% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -7892.804% |
| OKYO Pharma Limited | -826.84 Thousand USD | -31963.572% |
| Savara Inc. | 153 Thousand USD | 173379.085% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 2219.071% |
| Curis, Inc. | -23.88 Million USD | -1009.88% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -34064.034% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 22472.743% |
| BeiGene, Ltd. | -2.25 Billion USD | 88.233% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | -42.854% |
| Erasca, Inc. | -37.21 Million USD | -612.374% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -20485.328% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -20485.328% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -2461.022% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -2339.428% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -745.102% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -721.508% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -671.227% |
| Adicet Bio, Inc. | -138.78 Million USD | -91.024% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 233.854% |
| Aditxt, Inc. | 18.12 Million USD | 1563.047% |
| Adagene Inc. | -87.62 Million USD | -202.55% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -6264.7% |
| Quantum-Si incorporated | -118.55 Million USD | -123.62% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -3447.101% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -446.532% |
| Compugen Ltd. | -12.9 Million USD | -1954.533% |
| Generation Bio Co. | 31.44 Million USD | 943.033% |
| Astria Therapeutics, Inc. | -175.36 Million USD | -51.181% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -757.346% |
| Invivyd, Inc. | -198.47 Million USD | -33.576% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -193.693% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -10957.192% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -274.512% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -3784.498% |
| 2seventy bio, Inc. | 181.71 Million USD | 245.897% |
| Instil Bio, Inc. | 75.35 Million USD | 451.81% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -2818.922% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -8407.259% |
| GeoVax Labs, Inc. | -6.45 Million USD | -4008.692% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -919.693% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -6379.596% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -4989.595% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -103.46% |
| Evaxion Biotech A/S | 5.28 Million USD | 5114.655% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -135.517% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -101.959% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -414.69% |
| Cingulate Inc. | 3.08 Million USD | 8700.203% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -8926.796% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 3788.841% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -151.196% |
| Clearmind Medicine Inc. | -3.94 Million USD | -6624.357% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 2917.696% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 18282.024% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -388.641% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 1634.419% |
| ImmunityBio, Inc. | 618.22 Million USD | 142.884% |
| Korro Bio, Inc. | -132.94 Million USD | -99.422% |
| Kineta, Inc. | -4.54 Million USD | -5738.296% |
| BioVie Inc. | -17.73 Million USD | -1395.103% |
| Codexis, Inc. | -43.27 Million USD | -512.69% |
| Celularity Inc. | 65.19 Million USD | 506.684% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 457.686% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -8265.951% |
| Virax Biolabs Group Limited | -3.36 Million USD | -7778.794% |
| Cibus, Inc. | -8.07 Million USD | -3181.963% |
| IN8bio, Inc. | -16.38 Million USD | -1517.652% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 736536.111% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -7446.741% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 125.147% |
| Eyenovia, Inc. | 1.25 Million USD | 21162.73% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 1085.382% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -8075.054% |
| Elevation Oncology, Inc. | -19.11 Million USD | -1286.74% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -697.416% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -1259.156% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -350.305% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -1179.09% |
| Moolec Science SA | 117.61 Thousand USD | 225508.958% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -590.427% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -599.185% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -87.467% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -1078.56% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -3693.117% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -4843.576% |
| Humacyte, Inc. | -22.48 Million USD | -1079.031% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -950.301% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -14769.153% |
| Genelux Corporation | -6.89 Million USD | -3742.832% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -753.592% |
| Notable Labs, Ltd. | -9.77 Million USD | -2611.917% |
| Immunovant, Inc. | -635.22 Million USD | 58.264% |
| Quantum-Si incorporated | -118.55 Million USD | -123.62% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -6299.155% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 3402.815% |
| Acasti Pharma Inc. | -23 Million USD | -1052.432% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -7773.447% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | -56.616% |
| PepGen Inc. | -60.67 Million USD | -336.982% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -1286.16% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -30652.857% |
| Immuneering Corporation | -54.94 Million USD | -382.532% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -6207.072% |
| Belite Bio, Inc | -87.27 Million USD | -203.786% |
| XOMA Corporation | -29 Million USD | -814.197% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -275.005% |
| Bionomics Limited | 227 Million USD | 216.787% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -10366.522% |
| uniQure N.V. | -102.95 Million USD | -157.518% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -6264.7% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 747.401% |
| Forte Biosciences, Inc. | -11.96 Million USD | -2116.512% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -8468.192% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 250210.377% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -8075.054% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 3077.17% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -3474.933% |
| Altimmune, Inc. | -134.48 Million USD | -97.132% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | -42.921% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -10366.522% |
| Peak Bio, Inc. | 10.34 Million USD | 2663.955% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -93580.919% |
| Benitec Biopharma Inc. | -50.58 Million USD | -424.133% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -154.094% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 1449.539% |
| Zura Bio Limited | -99.8 Million USD | -165.632% |
| PolyPid Ltd. | 6.17 Million USD | 4396.872% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 1449.539% |
| argenx SE | -2.02 Billion USD | 86.933% |
| Immunome, Inc. | -97.02 Million USD | -173.235% |
| Verona Pharma plc | -220.44 Million USD | -20.266% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -269.537% |
| Shattuck Labs, Inc. | -121.42 Million USD | -118.34% |
| CervoMed Inc. | -7.79 Million USD | -3302.056% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -5962.589% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -101.243% |
| Moolec Science SA | 117.61 Thousand USD | 225508.958% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -11487.398% |
| Design Therapeutics, Inc. | -18.15 Million USD | -1360.7% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -276.688% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 2460.372% |
| Achilles Therapeutics plc | -126.92 Million USD | -108.879% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 18282.024% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -3463.401% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 177.93% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 1216.988% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 40.752% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -88.95% |
| Beam Therapeutics Inc. | -262.72 Million USD | -0.912% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 1315.241% |
| AEON Biopharma, Inc. | -4.88 Million USD | -5332.725% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -374.576% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -165.489% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -11192.18% |
| NeurAxis, Inc. | 145.7 Thousand USD | 182060.879% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -579.334% |
| Lumos Pharma, Inc. | -28.49 Million USD | -830.464% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -1176.207% |
| Palisade Bio, Inc. | -12.06 Million USD | -2097.77% |
| Nutriband Inc. | -251.65 Thousand USD | -105248.55% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -218.336% |
| Neurogene Inc. | -131.95 Million USD | -100.915% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -5300.631% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 29.713% |
| Athira Pharma, Inc. | -88.99 Million USD | -197.888% |
| HCW Biologics Inc. | 2.85 Million USD | 9380.611% |
| XOMA Corporation | -29 Million USD | -814.197% |
| Nektar Therapeutics | 210.24 Million USD | 226.102% |
| Arvinas, Inc. | -313.8 Million USD | 15.514% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 16436.104% |
| Merus N.V. | -192.88 Million USD | -37.449% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 541.972% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -3721.231% |
| Rezolute, Inc. | -68.16 Million USD | -288.917% |
| Clene Inc. | 3.34 Million USD | 8037.635% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -1910.442% |
| BeyondSpring Inc. | -13.75 Million USD | -1827.423% |
| Synlogic, Inc. | -6.68 Million USD | -3865.849% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 23478.924% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -3035.624% |
| Peak Bio, Inc. | 10.34 Million USD | 2663.955% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -221.666% |
| Krystal Biotech, Inc. | -350.23 Million USD | 24.303% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 313.589% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | -56.878% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -8297.368% |
| MannKind Corporation | 143.89 Million USD | 284.238% |
| Ikena Oncology, Inc. | -109.15 Million USD | -142.879% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -3401.743% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -700.958% |
| Gossamer Bio, Inc. | 180.35 Million USD | 246.997% |
| CohBar, Inc. | -5.93 Million USD | -4370.225% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -791.209% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 5906.329% |
| Legend Biotech Corporation | -949.39 Million USD | 72.075% |
| Mural Oncology plc | -255.84 Million USD | -3.625% |
| Disc Medicine, Inc. | -358.28 Million USD | 26.003% |
| Champions Oncology, Inc. | 4.81 Million USD | 5609.497% |
| REGENXBIO Inc. | 54.76 Million USD | 584.073% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -98490.591% |
| Anavex Life Sciences Corp. | -151.02 Million USD | -75.546% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -2841.82% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -228.591% |
| Vaxart, Inc. | -8.24 Million USD | -3117.049% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -428.332% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -108.482% |
| Cellectis S.A. | -43.85 Million USD | -504.531% |
| Longeveron Inc. | -2.9 Million USD | -9016.816% |
| Repare Therapeutics Inc. | -107.85 Million USD | -145.802% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 127.377% |
| Inozyme Pharma, Inc. | 12 Million USD | 2308.572% |
| Revolution Medicines, Inc. | -608.2 Million USD | 56.41% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -21454.228% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -76.66% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -1594.363% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -35726.622% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 97.228% |
| Denali Therapeutics Inc. | -74.86 Million USD | -254.127% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -2110.837% |
| Veru Inc. | 4.77 Million USD | 5646.417% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -2257.434% |
| Cingulate Inc. | 3.08 Million USD | 8700.203% |
| Passage Bio, Inc. | 4.58 Million USD | 5882.268% |
| Context Therapeutics Inc. | -14.44 Million USD | -1734.742% |
| Exicure, Inc. | 5.84 Million USD | 4632.689% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | -15.08% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -569.995% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 1789.612% |
| Nuvalent, Inc. | -335.38 Million USD | 20.952% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 15386.325% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -255.948% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -2882.193% |
| OmniAb, Inc. | 9.2 Million USD | 2980.767% |
| Anew Medical, Inc. | 1.43 Million USD | 18607.747% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 1718.368% |
| Lipocine Inc. | -4.75 Million USD | -5476.02% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -141.393% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 1840.641% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -423.336% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 1165.069% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -3844.606% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -302.748% |
| Ocugen, Inc. | -32.52 Million USD | -715.218% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -209.807% |
| Q32 Bio Inc. | -37.94 Million USD | -598.632% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -42116.083% |
| Alumis Inc. Common Stock | -13.52 Million USD | -1859.62% |
| Equillium, Inc. | -22.39 Million USD | -1083.981% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -936.909% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -712.575% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -106838.668% |
| Dominari Holdings Inc. | 195 Thousand USD | 136057.436% |
| Edesa Biotech, Inc. | -5.26 Million USD | -4933.635% |
| vTv Therapeutics Inc. | -8.91 Million USD | -2873.164% |
| Bio-Techne Corporation | 267.74 Million USD | 199.018% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -1535.616% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -124.497% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -3055.028% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -1995.621% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | -8.158% |
| Nkarta, Inc. | 57.29 Million USD | 562.69% |
| BioCardia, Inc. | 212 Thousand USD | 125155.189% |
| Iterum Therapeutics plc | 13.43 Million USD | 2072.89% |